Guillermo D. V. O. D. R.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase I Evaluation of FS222 for Safety and Efficacy in Patients with Advanced Malignancies
- Evaluation of FS120 Monotherapy and FS120 with Pembrolizumab in Patients with Advanced Malignancies: A First-in-Human Safety and Efficacy Study
- A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of PF-08046876 in Participants with Advanced Solid Tumors
Data & Insights
Has run more than one trial at 181 of 355 partner sites.
Specializations
Oncology Focus
This investigator specializes in treating advanced malignancies, with particular emphasis on solid tumor therapeutics and innovative combination treatment approaches.
- Metastatic solid tumors
- Platinum-resistant ovarian cancer
- Advanced melanoma
Their work encompasses both traditional and novel therapeutic strategies in oncology.
Thoracic Oncology
The investigator has developed expertise in thoracic malignancies, focusing on both early-stage and advanced disease states.
- Non-small cell lung cancer
- Small cell lung cancer
- Neoadjuvant therapy approaches
Their interest extends to various treatment lines and therapeutic combinations in lung cancer management.
Specialized Cancer Areas
The investigator has dedicated focus on specific cancer types requiring targeted therapeutic approaches.
- HER2-positive breast cancer
- Cervical cancer
- Immunotherapy applications
Their expertise includes managing both early-stage disease and advanced therapeutic settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.